NWPHF (Newron Pharmaceuticals SpA) Float Percentage Of Total Shares Outstanding: 0.00% (As of Jul. 04, 2026)


NWPHF Newron Pharmaceuticals SpA NWPHF
64 GF Score
Price $20.00
GF Value $20.44
! 5 Warning Signs
View Full Analysis

What is Newron Pharmaceuticals SpA Float Percentage Of Total Shares Outstanding?

Newron Pharmaceuticals SpA NWPHF 64 Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 04, 2026. GuruFocus rates NWPHF with a GF Score™ of 64/100 and a GF Value™ of $20.44. The stock has 5 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Newron Pharmaceuticals SpA's float shares is 0.00 Mil. Newron Pharmaceuticals SpA's total shares outstanding is 20.81 Mil. Newron Pharmaceuticals SpA's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Newron Pharmaceuticals SpA's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Newron Pharmaceuticals SpA's Institutional Ownership is 4.79%.

NWPHF
64GF Score
Newron Pharmaceuticals SpA NWPHF
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Newron Pharmaceuticals SpA Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Newron Pharmaceuticals SpA's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/20.81
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 0.00% mean?
Newron Pharmaceuticals SpA (NWPHF) has a Float Percentage Of Total Shares Outstanding of 0.00% as of Jul. 04, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Newron Pharmaceuticals SpA and its competitors.
Is Newron Pharmaceuticals SpA's Float Percentage Of Total Shares Outstanding too high?
Newron Pharmaceuticals SpA's current Float Percentage Of Total Shares Outstanding is 0.00%. Overall, Newron Pharmaceuticals SpA has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does Newron Pharmaceuticals SpA's Float Percentage Of Total Shares Outstanding compare to VRTX and REGN?
Newron Pharmaceuticals SpA's Float Percentage Of Total Shares Outstanding of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Newron Pharmaceuticals SpA and its competitors. Newron Pharmaceuticals SpA's current Float Percentage Of Total Shares Outstanding is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Newron Pharmaceuticals SpA stock overvalued right now?
Newron Pharmaceuticals SpA (NWPHF) has a current Float Percentage Of Total Shares Outstanding of 0.00%. The stock's GF Value™ is $20.44, compared to a current price of $20.00 — trading 2.2% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 0.00%. Newron Pharmaceuticals SpA's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Newron Pharmaceuticals SpA (NWPHF), the current Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Newron Pharmaceuticals SpA (NWPHF) Overvalued in 2026?

Based on GuruFocus' analysis, Newron Pharmaceuticals SpA stock appears to be undervalued. The current stock price of $20.00 is trading 2.2% below its estimated GF Value™ of $20.44.

Key valuation signals for NWPHF:

  • Float Percentage Of Total Shares Outstanding: 0.00%
  • GF Value™: $20.44 vs. price of $20.00 (2.2% below fair value)
  • GF Score™: 64/100 with 5 warning signs

No single metric tells the full story. See the NWPHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Newron Pharmaceuticals SpA Business Description

Address Via Antonio Meucci 3, Bresso, Milan, ITA, 20091
Newron Pharmaceuticals SpA is a Italy-based clinical-stage biopharmaceutical company. It focuses on the discovery and development of pharmaceutical products. The Company is engaged in discovering and developing new therapies for diseases of the Central Nervous System (CNS) and pain. The Company undertakes phase III trials with safinamide molecule for the treatment of patients with Parkinson's disease. Newron Pharmaceuticals SpA develops ralfinamide, a molecule for the treatment of neuropathic pain. Geographically the research and development activities are performed in Italy and the United States.
64GF Score

Get the complete analysis for NWPHF

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$20.00
Price
$20.44
GF Value